Bg Medicine
(OTC) BGMD
Bg Medicine Financials at a Glance
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$1.57M
Net Income (TTM)
-$5.30M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
14.06 (High)
Dividend
$0.00
Beta (Volatility)
14.06 (High)
Price
$0.00
Volume
5,100
Open
$0.00
Price
$0.00
Volume
5,100
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
Feb 26, 2025
Dividend
$0.00
Beta (Volatility)
14.06 (High)
Price
$0.00
Volume
5,100
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Estimated Earnings Date
Feb 26, 2025
BGMD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bg Medicine
BGMD Financials
Key Financial Metrics (TTM)
Gross Margin
67.75%
Operating Margin
-295.66%
Net Income Margin
-338.63%
Return on Equity
747.43%
Return on Capital
N/A
Return on Assets
-248.62%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-47.14%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
11.37M
Volume
5.10K
Avg. Volume
98.887
Financials (TTM)
Gross Profit
$1.06M
Operating Income
-$4.63M
EBITDA
-$5.06M
Operating Cash Flow
-$3.67M
Capital Expenditure
$0.00
Free Cash Flow
-$3.67M
Cash & ST Invst.
$1.53M
Total Debt
$0.00
Bg Medicine Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$290.00K
-47.7%
Gross Profit
$208.00K
-42.5%
Gross Margin
71.72%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
5
N/A
Net Income
-$902.00K
+31.6%
EBITDA
-$884.00K
+23.7%
Quarterly Fundamentals
Total Cash
$1.53M
-63.0%
Total Debt
$0.00
-100.0%
Accounts Receivable
$181.00K
+4.0%
Inventory
$145.00K
-63.7%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-2.49%
N/A
Return on Invested Capital
-4.86%
N/A
Free Cash Flow
-$1.12M
-4.4%
Operating Cash Flow
-$1.12M
-4.4%